TipRanks
Go Ultimate55% OFF

Glenn Muir Insider Profile

200 Followers

Glenn Muir, Director at Cytek Biosciences, holds 3.09K shares in Cytek Biosciences (Ticker: CTKB), holds 401.82K shares in Neuronetics (Ticker: STIM), holds 40.05K shares in Repligen (Ticker: RGEN).

Glenn Muir's Trading History

CTKB
Cytek Biosciences
Aug 20, 2026DirectorUninformative Buy14.41K$18.92K
STIM
Neuronetics
May 29, 2026DirectorUninformative Buy―$904.09K
RGEN
Repligen
May 18, 2026DirectorUninformative Buy―$7.09M
GTHX
G1 Therapeutics
Sep 18, 2024―Uninformative Sell―$0.00
LFWD
Lifeward
Dec 31, 2015DirectorUninformative Buy―$35.84K
HOLX
Hologic
May 12, 2014―Informative Sell1.21M$61.97M

You May Also Like

Glenn Muir insider profile FAQ

What is the percentage of profitable transactions made by Glenn Muir?
The percentage of profitable transactions made by Glenn Muir is 63%.
What is the average return per transaction made by Glenn Muir?
The average return per transaction made by Glenn Muir is 114.80%.
What stocks does Glenn Muir hold?
Glenn Muir holds: CTKB, RGEN, LFWD, GTHX, STIM, HOLX stocks.
What was Glenn Muir’s latest transaction?
Glenn Muir’s latest transaction was an Uninformative Buy of $14.41K.
What was Glenn Muir's most profitable transaction?
Glenn Muir’s most profitable transaction was an Informative Buy of STIM stock on September 6, 2024. The return on the trade was 316.70%.
What is Glenn Muir's role in Cytek Biosciences?
Glenn Muir's role in Cytek Biosciences is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.